Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications
<p>Due to the strong association between diabetes and cancer incidents, several anti-diabetic drugs, including metformin, have been examined for their anticancer activity. Metformin is a biguanide antihyperglycemic agent used as a first-line drug for type II diabetes mellitus. It exhibits anti...
محفوظ في:
| المؤلف الرئيسي: | Sara S Bashraheel (17807612) (author) |
|---|---|
| مؤلفون آخرون: | Hadeel Kheraldine (14231609) (author), Sarah Khalaf (16555642) (author), Ala-Eddin Al Moustafa (5472368) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer
حسب: Kheraldine, Hadeel
منشور في: (2025) -
Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways
حسب: Hadeel, Kheraldine
منشور في: (2021) -
Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
حسب: Rasha M. Sareyeldin (18131371)
منشور في: (2019) -
Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways
حسب: Hadeel Kheraldine (14231609)
منشور في: (2021) -
Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways
حسب: Hadeel Kheraldine (14231609)
منشور في: (2024)